Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia (2021)
Source: New england journal of medicine. Unidade: FM
Subjects: COVID-19, FARMACOTERAPIA, PACIENTES INTERNADOS, INSUFICIÊNCIA RESPIRATÓRIA, FÁRMACOS SINTÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARAES, Patricia O et al. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. New england journal of medicine, v. 385, n. 5, p. 406-415, 2021Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2101643. Acesso em: 05 out. 2024.APA
Guimaraes, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., et al. (2021). Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. New england journal of medicine, 385( 5), 406-415. doi:10.1056/NEJMoa2101643NLM
Guimaraes PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia [Internet]. New england journal of medicine. 2021 ; 385( 5): 406-415.[citado 2024 out. 05 ] Available from: https://doi.org/10.1056/NEJMoa2101643Vancouver
Guimaraes PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia [Internet]. New england journal of medicine. 2021 ; 385( 5): 406-415.[citado 2024 out. 05 ] Available from: https://doi.org/10.1056/NEJMoa2101643